Compare Vaxcyte Inc. Common Stock (PCVX) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Victoria's Secret & Co — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while Victoria's Secret & Co trades at $86.8 (market cap $7.08B). The key difference: Vaxcyte Inc. Common Stock is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is more actively traded (2,644,694 versus 1,247,026). Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Victoria's Secret & Co for 34 Days on average.
| PCVX | VSXY | |
|---|---|---|
Market Cap | $10.51B | $7.08B |
Volume | 2,644,694 | 1,247,026 |
Sector | Health | Consumer Cyclical |
52-Week High | $73.82 | $99.97 |
52-Week Low | $40.32 | $30.19 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $9.14B | $9.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Victoria's Secret (VSXY) trades at $88.39, down 0.23% today, with a bullish technical signal supported by moving averages. The company shows improving fundamentals with three consecutive quarterly earnings beats and projected 2026 revenue growth to $6.9B. Recent news highlights brand momentum through fashion show expansion and omnichannel retail strategy, though valuation remains elevated at P/E 19.83 and P/B 7.16.
The outlook appears positive with 60% analyst buy ratings and projected net income growth to $378M in 2026. Key opportunities include international expansion and margin improvement, while risks involve rich valuation, rising costs, and competitive pressures in retail apparel. The stock trades near consensus target of $86.80 with upside potential to $101.00.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
